Moreover, the in vivo limiting assay indicated a substantial reduction in the tumorigenic capacity of hepatoma cells upon lncRNA FOXD1-AS1 knockdown (Fig. 2F). The gene discussed is FOXD1; the disease is hepatocellular carcinoma.